Clinical Trials Directory

Trials / Completed

CompletedNCT01010477

Trial of Nicotine Nasal Spray as an Aid for Smoking Cessation in Schizophrenia

Double-Blind, Placebo-Controlled Trial of Nicotine Nasal Spray as an Aid for Smoking Cessation in Schizophrenia

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
66 (actual)
Sponsor
Rutgers, The State University of New Jersey · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This R01 grant describes a randomized, double-blind, placebo-controlled trial of nicotine nasal spray (NNS) as an aid for smoking cessation in 60 individuals with schizophrenia. The objectives of this study are to determine the efficacy of NNS with behavioral intervention for smoking cessation in smokers with schizophrenia. It is hypothesized that the quit rate of subjects who receive NNS and behavioral intervention will be significantly greater than the quit rate of the control group who will receive the placebo spray plus same behavioral intervention. Quit rate is defined as the proportion of individuals who self report no tobacco use during weeks 5 through 8 confirmed by exhaled carbon monoxide (CO) less than 10 parts per million during these 4 weeks. The investigators will also assess abstinence rates at Study Weeks 12 and 20 on the NNS and at weeks 26 and 52 after the medication has been stopped. Since studies of this group suggest high relapse rates when treatments are discontinued (Evins et al., 2005; George et al., 2000; George et al., 2002a), the investigators will continue NNS treatment for a total of 20 weeks.

Conditions

Interventions

TypeNameDescription
DRUGNicotine Nasal Sprayminimum 8 doses of nasal spray per day; maximum of 5 doses per hour, no more than 40 doses per day
BEHAVIORALBehavioral counselingBoth groups will receive behavioral intervention designed for schizophrenia delivered as 15 individual counseling sessions over 26 weeks.

Timeline

Start date
2009-08-01
Primary completion
2012-07-01
Completion
2012-08-01
First posted
2009-11-10
Last updated
2014-09-08
Results posted
2014-09-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01010477. Inclusion in this directory is not an endorsement.